Ether

Ether

SCHEMBL2123609

CCOCC.ClCCCl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL22714171 0.88
Ether SCHEMBL5128631 0.87 ALDH1A1 (0.39)
Ether SCHEMBL9494752 0.87 ALDH1A1 (0.39)
Ether SCHEMBL317157 0.87 ALDH1A1 (0.39)
Ether SCHEMBL317310 0.87 ALDH1A1 (0.39)
Ether SCHEMBL9333712 0.87 ALDH1A1 (0.39)
Ether SCHEMBL9258257 0.87 ALDH1A1 (0.39)
Ether SCHEMBL9567021 0.87 ALDH1A1 (0.39)
Ether SCHEMBL3439245 0.87 ALDH1A1 (0.39)
Ether SCHEMBL1331 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108727339-A A kind of preparation method of 3- amino -3- quaternary carbon oxidized indole compounds 中国科学院成都有机化学有限公司 2018-11-02 CN claimed
CN-106987152-A One class fluorine boron near infrared fluorescent dye and the application in non-protonic solvent in the detection of minor amount of water 三峡大学 2017-07-28 CN claimed
CN-106947281-A One class fluorine boron near infrared fluorescent dye and the application in non-protonic solvent in the detection of micro ethanol 三峡大学 2017-07-14 CN claimed
CN-106831839-A One class fluorine boron near infrared fluorescent dye and the application in the non-protonic solvent in the detection of Trace Methanol 三峡大学 2017-06-13 CN claimed
CN-103880807-B The synthesis technique of high-purity alpha-mangostin 杭州博麦医药科技有限公司 2016-09-28 CN claimed
CN-102464657-A Chiral binuclear ligand containing two oxazolines and having pyridazine or phthalazine matrix skeleton and synthetic method thereof UNIV SHANGHAI JIAOTONG 2012-05-23 CN claimed
US-20230390966-A1 SYSTEMS AND METHODS FOR PRODUCTION OF MATERIALS USED IN ADDITIVE MANUFACTURING APPLIED CAVITATION, INC. (US) 2023-12-07 US disclosed
EP-4228898-A1 SYSTEMS AND METHODS FOR PRODUCTION OF MATERIALS USEFUL IN ADDITIVE MANUFACTURING Applied Cavitation, Inc. (US) 2023-08-23 EP disclosed
WO-2022081913-A1 SYSTEMS AND METHODS FOR PRODUCTION OF MATERIALS USEFUL IN ADDITIVE MANUFACTURING APPLIED CAVITATION, INC. (US) 2022-04-21 WO disclosed
US-20220111560-A9 SYSTEMS AND METHODS FOR PRODUCING MATERIALS SUITABLE FOR ADDITIVE MANUFACTURING USING A HYDRODYNAMIC CAVITATION APPARATUS APPLIED CAVITATION, INC. (US) 2022-04-14 US disclosed
US-20200215724-A1 SYSTEMS AND METHODS FOR PRODUCING MATERIALS SUITABLE FOR ADDITIVE MANUFACTURING USING A HYDRODYNAMIC CAVITATION APPARATUS APPLIED CAVITATION, INC. (US) 2020-07-09 US disclosed
US-10676399-B2 Systems and methods for additive manufacturing using ceramic materials APPLIED CAVITATION, INC. (US) 2020-06-09 US disclosed
US-10589447-B2 Systems and methods for producing materials suitable for additive manufacturing using a hydrodynamic cavitation apparatus APPLIED CAVITATION, INC. (US) 2020-03-17 US disclosed
US-6063748-A PERFLUOROBUTYL ETHYL ETHER AND PERFLUOROISOBUTYL ETHYL ETHER WITH SOLVENT 3M INNOVATIVE PROPERTIES COMPANY (US) 2000-05-16 US disclosed
EP-0718295-B1 Lactones with antioxidising and hypolipidaemic activity useful in the therapy of the atherosclerosis ALFA WASSERMANN SPA (IT) 1998-04-22 EP disclosed
US-5608084-A AND VASCULAR PATHOLOGIES; MULTISTEP PREPARATION BY REACTING A HYDROQUINONE WITH ALKYL VINYL KETONE, ESTERIFYING HYDROXY 3,4-DIHYDRO-2H-1-BENZOPYRAN, DEMETHYLATING ETHER, REACTING WITH ALKYL 5-BROMOPENTANOATE, HYDROLYZING, TWO MORE STEPS ALFA WASSERMANN S.P.A. (IT) 1997-03-04 US disclosed
EP-0718295-A1 Lactones with antioxidising and hypolipidaemic activity useful in the therapy of the atherosclerosis ALFA WASSERMANN S.p.A. (IT) 1996-06-26 EP disclosed
CN-1107146-A A process for preparing a composition containing benzoheterocycles OTSUKA PHARMA CO LTD (JP) 1995-08-23 CN disclosed
CN-1093701-A Antiretroviral hydrazine derivative CIBA GEIGY AG (CH) 1994-10-19 CN disclosed
US-4010176-A Isoxazole substituted nitroimidazoles MERCK & CO., INC. (US) 1977-03-01 US disclosed